<http://webisa.webdatacommons.org/331281452>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/331281452>	<http://www.w3.org/ns/prov#value>	"Such reference levels could be used for comparison to the levels of the one or more biomarkers in a biological sample from a subject.V. Monitoring Therapeutic Efficacy:The biomarkers provided also allow for the assessment of the efficacy of a composition for treating a disease or condition such as insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, or cardiomyop" .
<http://webisa.webdatacommons.org/prov/193080410>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/331281452> .
<http://webisa.webdatacommons.org/331281452>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<freepatentsonline.com> .
<http://webisa.webdatacommons.org/prov/340785519>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/331281452> .
<http://webisa.webdatacommons.org/prov/219000075>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/331281452> .
<http://webisa.webdatacommons.org/prov/185392479>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/331281452> .